Article
Bovine major histocompatibility complex (BoLA) heterozygote advantage against the outcome of bovine leukemia virus infection.
HLA - 1 Aug 2021
Lo Chieh-Wen, Takeshima Shin-Nosuke, Wada Satoshi, Matsumoto Yasunobu, Aida Yoko
Abstract excerpt
Bovine leukemia virus (BLV) causes enzootic bovine leucosis. Host genetic heterozygosity at the major histocompatibility complex can enhance the ability to combat infectious diseases. However, heterozygote advantage is loci specific and depends on disease type. Bovine leukocyte antigen (BoLA)-DRB3 polymorphisms are related with BLV-infection outcome; however, whether BoLA-DRB3 heterozygotes have an advantage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
